Physician

Munsoor Lateef, MD

According to 2025 Medicare claims, Munsoor Lateef, MD (NPI: 1073716742) practices nephrology in the Burlington, NC market, with the plurality of this provider's patient population coming from Alamance, NC. This provider's primary affiliated billing organization is CENTRAL CAROLINA KIDNEY ASSOCIATES PA (NPI: 1356582506; TIN: 264116711) and primary practice location at 27215-8700. Lateef is affiliated with the Triad HealthCare Network, LLC. (ACO ID: D0209), participating under the REACH model.

Lateef's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 305 traditional Medicare patients, billed 1,489 HCPCS/CPT codes, and received $164,351 in Medicare payments. The top billing code was 90960 (Dialysis services, 4 or more physician visits per month (20 years or older)). Part D data shows 2,214 prescription claims across 369 beneficiaries totaling $714,468 in drug costs, led by Jynarque (Tolvaptan). DME data shows 62 claims. Open Payments data shows 30 records totaling $688. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $204,728 to $714,468. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	417	2,172	$210,336
2016	392	1,830	$194,259
2017	392	1,979	$197,187
2018	392	1,984	$188,055
2019	406	2,261	$220,104
2020	422	2,243	$250,036
2021	364	2,120	$289,615
2022	331	1,906	$254,134
2023	389	1,665	$223,948
2024	305	1,489	$164,351

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	217	1,642	$204,728
2016	236	1,826	$397,182
2017	277	2,800	$535,204
2018	321	3,003	$396,468
2019	299	2,336	$329,460
2020	280	2,218	$464,064
2021	289	2,148	$433,841
2022	287	1,797	$341,949
2023	373	2,159	$637,548
2024	369	2,214	$714,468

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	54	$3,130
2016	N/R	46	$1,963
2017	N/R	33	$1,515
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	46	$1,950
2023	N/R	48	$1,151
2024	N/R	62	$1,321

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
90960	Dialysis services, 4 or more physician visits per month (20 years or older)	50	279	$247
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	49	111	$86
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	128	325	$83
99232	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes	85	403	$58
G2211	Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's	39	88	$12

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Jynarque	Tolvaptan	14	392	$282,102
Farxiga	Dapagliflozin Propanediol	269	11,551	$215,845
Jardiance	Empagliflozin	126	3,840	$72,361
Veltassa	Patiromer Calcium Sorbitex	23	855	$28,467
Sevelamer Carbonate	Sevelamer Carbonate	41	1,800	$6,209

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7507	Tacrolimus, immediate release, oral, 1 mg	N	N/R	15	$672
Q0511	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for the first prescription in a 30-day period	N	N/R	19	$301
Q0512	Pharmacy supply fee for oral anti-cancer, oral anti-emetic or immunosuppressive drug(s); for a subsequent prescription in a 30-day period	N	N/R	17	$201
J7517	Mycophenolate mofetil, oral, 250 mg	N	N/R	11	$148

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	30	$688	Hologic Sales and Service, LLC
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Munsoor Lateef, MD?

Tedicare shows public-source Medicare data for Munsoor Lateef, MD (NPI 1073716742), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Munsoor Lateef, MD have ACO affiliation data?

Munsoor Lateef, MD is shown with ACO affiliation data for Triad HealthCare Network, LLC. (REACH, ACO ID D0209).

What billing organization is linked to Munsoor Lateef, MD?

Munsoor Lateef, MD is linked to CENTRAL CAROLINA KIDNEY ASSOCIATES PA (billing NPI 1356582506) in the available physician profile data.

Does Munsoor Lateef, MD have Open Payments data?

Munsoor Lateef, MD has 30 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.